These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9301980)

  • 1. Management of infections due to resistant enterococci: a review of therapeutic options.
    Landman D; Quale JM
    J Antimicrob Chemother; 1997 Aug; 40(2):161-70. PubMed ID: 9301980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview.
    Francioli P
    Eur Heart J; 1995 Apr; 16 Suppl B():75-9. PubMed ID: 7671930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and control of multiresistant enterococci.
    Leclercq R
    Drugs; 1996; 52 Suppl 2():47-9. PubMed ID: 8869836
    [No Abstract]   [Full Text] [Related]  

  • 5. Vancomycin-resistant enterococcal infections.
    Murray BE
    N Engl J Med; 2000 Mar; 342(10):710-21. PubMed ID: 10706902
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci.
    Leone S; Noviello S; Esposito S
    Infection; 2016 Jun; 44(3):273-81. PubMed ID: 26324294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococci acquire new kinds of resistance.
    Leclercq R
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S80-4. PubMed ID: 8994783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of using relapse studies or tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective.
    Caron F
    J Infect Dis; 1997 Jan; 175(1):232-3. PubMed ID: 8985229
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen.
    Spera RV; Farber BF
    Drugs; 1994 Nov; 48(5):678-88. PubMed ID: 7530626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular infections caused by enterococci highly resistant to ampicillin.
    Chirurgi VA; Oster SE; Goldberg AA; McCabe RE
    South Med J; 1991 Dec; 84(12):1435-7. PubMed ID: 1749972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aminoglycoside-resistant enterococci a new bacterial hazard].
    Melhus A
    Lakartidningen; 1999 Apr; 96(14):1694-5. PubMed ID: 10222683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterococcal infections. The increasing threat of nosocomial spread and drug resistance.
    Vemuri RK; Zervos MJ
    Postgrad Med; 1993 Feb; 93(3):121-4, 127-8. PubMed ID: 8446521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococci: susceptibility patterns and therapeutic options.
    Nicoletti G; Stefani S
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S33-7. PubMed ID: 7729470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enterococcal endocarditis, a model of therapeutic difficulty].
    Fernández Guerrero ML; Núñez García A
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():41-5. PubMed ID: 9441316
    [No Abstract]   [Full Text] [Related]  

  • 16. A potential role for daptomycin in enterococcal infections: what is the evidence?
    Cantón R; Ruiz-Garbajosa P; Chaves RL; Johnson AP
    J Antimicrob Chemother; 2010 Jun; 65(6):1126-36. PubMed ID: 20363805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
    Landman D; Quale JM; Mobarakai N; Zaman MM
    J Antimicrob Chemother; 1995 Jul; 36(1):253-8. PubMed ID: 8537276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging resistance in Enterococcus spp.
    Heath CH; Blackmore TK; Gordon DL
    Med J Aust; 1996 Jan; 164(2):116-20. PubMed ID: 8569563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterococci in orthopaedic infections: Who is at risk getting infected?
    Uçkay I; Pires D; Agostinho A; Guanziroli N; Öztürk M; Bartolone P; Tscholl P; Betz M; Pittet D
    J Infect; 2017 Oct; 75(4):309-314. PubMed ID: 28676409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.